Common Name |
Salicylamide
Description |
Salicylamide is the common name for the substance o-hydroxybenzamide, or amide of salicyl. Salicylamide is a non-prescription drug with analgesic and antipyretic properties. Its medicinal uses are similar to those of aspirin. Salicylamide is used in combination with both aspirin and caffeine in the over-the-counter pain remedies
Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Synonyms |
Value |
Source |
2-CarbamoylphenolChEBI
2-CarboxamidophenolChEBI
2-HydroxybenzamideChEBI
O-HydroxybenzamideChEBI
OHBChEBI
SalicilamidaChEBI
SalicylamidumChEBI
Salicylic acid amideChEBI
Salicylate amideGenerator
Salicylamide slifateMeSH
Salicylamide, 3H-labeledMeSH
Salicylamide, monosodium saltMeSH
Salicylamide, calcium (2:1) saltMeSH
Chemical Formlia |
C7H7NO2
Average Molecliar Weight |
137.136
Monoisotopic Molecliar Weight |
137.047678473
IUPAC Name |
2-hydroxybenzamide
Traditional Name |
salicylamide
CAS Registry Number |
65-45-2
SMILES |
NC(=O)C1=CC=CC=C1O
InChI Identifier |
InChI=1S/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10)
InChI Key |
SKZKKFZAGNVIMN-UHFFFAOYSA-N
Chemical Taxonomy |
Description |
This compound belongs to the class of chemical entities known as 1-hydroxy-4-unsubstituted benzenoids. These are phenols that are unsubstituted at the 4-position.
Kingdom |
Chemical entities
Super Class |
Organic compounds
Class |
Benzenoids
Sub Class |
Phenols
Direct Parent |
1-hydroxy-4-unsubstituted benzenoids
Alternative Parents |
1-hydroxy-2-unsubstituted benzenoids
Benzene and substituted derivatives
Carboximidic acids
Organopnictogen compounds
Organooxygen compounds
Organonitrogen compounds
Hydrocarbon derivatives
Substituents |
1-hydroxy-4-unsubstituted benzenoid
1-hydroxy-2-unsubstituted benzenoid
Monocyclic benzene moiety
Carboximidic acid derivative
Carboximidic acid
Organic nitrogen compound
Organic oxygen compound
Organopnictogen compound
Hydrocarbon derivative
Organooxygen compound
Organonitrogen compound
Aromatic homomonocyclic compound
Molecliar Framework |
Aromatic homomonocyclic compounds
External Descriptors |
phenols (CHEBI:32114 )
salicylamides (CHEBI:32114 )
a small moleclie (SALICYLAMIDE )
Ontology |
Status |
Expected but not Quantified
Origin |
Drug
Biofunction |
Analgesics
Antipyretics
Application |
Pharmaceutical
Cellliar locations |
Not Available
Physical Properties |
State |
Solid
Experimental Properties |
Property |
Value |
Reference |
Melting Point140 °CNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties |
Property |
Value |
Source |
Water Solubility7.82 mg/mLALOGPS
logP0.74ALOGPS
logP1.17ChemAxon
logS-1.2ALOGPS
pKa (Strongest Acidic)8.21ChemAxon
pKa (Strongest Basic)-1.8ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area63.32 Å2ChemAxon
Rotatable Bond Count1ChemAxon
Refractivity37.12 m3·mol-1ChemAxon
Polarizability13.22 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
Spectra |
Spectra |
Spectrum Type |
Description |
Splash Key |
|
LC-MS/MS |
LC-MS/MS Spectrum – LC-ESI-TOF , negativesplash10-000i-1900000000-132217380eb9a2784eb0View in MoNA
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, NegativeNot Available
Biological Properties |
Cellliar Locations |
Not Available
Biofluid Locations |
Blood
Urine
Tissue Location |
Not Available
Pathways |
Not Available
Normal Concentrations |
Biofluid |
Status |
Age |
Condition |
Reference |
Details |
BloodExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB08797
21059682
details
UrineExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB08797
21059682
details
|
Abnormal Concentrations |
|
Not Available
Associated Disorders and Diseases |
Disease References |
None
Associated OMIM IDs |
None
External Links |
DrugBank ID |
DB08797
DrugBank Metabolite ID |
Not Available
Phenol Explorer Compound ID |
Not Available
Phenol Explorer Metabolite ID |
Not Available
FoodDB ID |
Not Available
KNApSAcK ID |
Not Available
Chemspider ID |
4963
KEGG Compound ID |
Not Available
BioCyc ID |
Not Available
BiGG ID |
Not Available
Wikipedia Link |
Salicylamide
NuGOwiki Link |
HMDB15687
Metagene Link |
HMDB15687
METLIN ID |
Not Available
PubChem Compound |
5147
PDB ID |
Not Available
ChEBI ID |
32114
Product: Sulfacetamide (Sodium)
References |
Synthesis Reference |
Not Available |
Material Safety Data Sheet (MSDS) |
Download (PDF) |
General References |
Not Available |
PMID: 16273120